BTK and diffuse large B-cell lymphoma: Ibrutinib resistance is mostly due to specific mutation of BTK or phospholipase gamma downstream of BTK, and these mutations frequently lead to a Richter transformation from chronic lymphocytic leukemia to diffuse large B cell lymphoma.